Loading...
NPI 1720553761 · Omaha, NE · Durable Medical Equipment & Medical Supplies
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Sakrx, LLC is a durable medical equipment & medical supplies provider located in Omaha, Nebraska. This profile covers 13 Medicare and 86 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Sakrx, LLC |
| Address | 12741 Q St |
| City | Omaha |
| State | NE |
| ZIP | 68137 |
| Taxonomy | Durable Medical Equipment & Medical Supplies |
| NPI Enumerated | October 5, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $9.6M |
| Medicare | $554.5K |
This provider is effectively Medicaid-focused: reported lifetime Medicaid revenue is $9.6M compared with total Medicare revenue of $554.5K, indicating the bulk of its billing and revenue activity is on Medicaid rather than Medicare. The scale difference suggests core operations and growth are driven by state DME/medical-supply contracts and high-volume consumables rather than Medicare services.
Medicaid revenue is concentrated in a few high-volume supply lines: the precomputed top 3 Medicaid codes account for 35.1% of the provider's total Medicaid revenue, led by B4150 ($1.5M, 16.0%), T4541 ($1M, 10.7%), and T4534 ($789.4K, 8.4%). Each of these codes is described as ranking #1 in-state (B4150, T4541, T4534 all 100th percentile with B4150 and T4541 flagged as "extreme outlier, far above typical state volume"), highlighting that a substantial share of Medicaid dollars flows from enteral formulas and disposable incontinence products.
The provider’s business mix, as reflected by top Medicaid codes, is concentrated in durable medical supplies and enteral nutrition: high claim counts for B4150 (12.6K claims), multiple T45xx incontinence product codes with thousands of claims (for example T4541 13.2K claims, T4534 6.3K claims), and an A4927 glove volume of 17.4K claims indicate operations focused on recurring consumable supplies and feeding products rather than episodic clinical procedures. This pattern is consistent with a DME/supplies distributor model that fills ongoing patient needs (enteral feeding, incontinence care, ostomy supplies) rather than inpatient devices or episodic services.
State-level competitive standing is dominant in key Medicaid categories: multiple Medicaid codes rank #1 in-state (including B4150, T4541, A4927 and several T45xx codes) and are labeled "extreme outlier" or "notably above typical" for state volume. That combination of top ranks and outlier labels suggests SAKRX, LLC is a major or market-leading supplier in Nebraska for enteral formulas and disposable incontinence products, giving it strong positioning within the state DME market.
Medicare activity is highly concentrated in vaccine administration: the precomputed top 3 Medicare codes account for 70.5% of the provider's total Medicare revenue, driven by vaccine product codes 91322 ($148.7K, 26.8%), 91320 ($131.8K, 23.8%), and 90694 ($110K, 19.8%). These entries indicate the provider participates in immunization services for Medicare beneficiaries—particularly COVID-19 and influenza vaccines—rather than broad clinical billing across other Medicare service lines.
National competitive signals for Medicare are mixed: 91322 and 91320 both rank in the 100th national percentile but are noted as "typical, unremarkable volume for this code," whereas 90694 ranks #29 of 51679 providers nationally (100th percentile) and is described as "notably above typical national volume for this code." In practical terms, the provider is a recognizably active vaccine administrator on national lists, with especially higher relative volume for influenza vaccine (90694) compared with many peers.
Tenure and operational history are sufficient to observe stable patterns: the NPI was enumerated on 2018-10-05 (~8 years ago), giving multiple years of claims for both Medicaid and Medicare to establish the strong DME/enteral focus on Medicaid and the complementary vaccine administration role on Medicare. This period of activity supports confidence in the identified payer mix and service-line orientation.
From an operational exposure viewpoint, the business is dependent on a narrow set of Medicaid product lines: with the top 3 Medicaid codes making up 35.1% of Medicaid revenue and many individual codes ranking as extreme outliers in-state, the provider’s revenue is sensitive to changes in state policy, reimbursement for enteral formulas and incontinence supplies, or shifts in procurement sourcing. That concentration suggests monitoring of state coverage rules and contract renewals would be prudent for payers and competitors assessing future revenue stability.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 1,040 | $140 | $148.7K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 1,030 | $130 | $131.8K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 1,450 | $80 | $110K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 2,090 | $40 | $79.3K |
| G0008 | Administration of influenza virus vaccine | 1,580 | $30 | $44.4K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 60 | $280 | $15.6K |
| 0134A | N/A | 230 | $40 | $8.7K |
| 0124A | N/A | 180 | $40 | $6.7K |
| 91304 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to prevent the patient from contracting COVID–19. The dosage is 5 mcg/0.5 mL. | 20 | $150 | $3K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 90 | $20 | $2K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
86 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| B4150 | Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100… | 12,620 | $120 | $1.5M |
| T4541 | Incontinence product, disposable underpad, large, each | 13,190 | $80 | $1M |
| T4534 | Youth sized disposable incontinence product, protective underwear/pull-on, each | 6,270 | $130 | $789.4K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 5,000 | $140 | $694.7K |
| T4525 | Adult sized disposable incontinence product, protective underwear/pull-on, small size, each | 5,870 | $120 | $681.3K |
| B4152 | Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include… | 3,130 | $180 | $563.6K |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals,… | 4,440 | $120 | $541.8K |
| B4154 | Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or… | 2,950 | $170 | $511K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 4,040 | $130 | $508.8K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 3,660 | $140 | $493.8K |
Showing 1–10 of 86
How this provider's Medicaid billing volume and revenue compare to other Nebraska providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nebraska median
86 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | 9 | 10 | 850 | $300 | $1M |
| B4161 | Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding… | 4 | 10 | 240 | $540 | $555.1K |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals,… | 2 | 10 | 650 | $180 | $533.1K |
| T4530 | Pediatric sized disposable incontinence product, brief/diaper, large size, each | 2 | 10 | 1,000 | $160 | $423.4K |
| T4534 | Youth sized disposable incontinence product, protective underwear/pull-on, each | 1 | 10 | 1,780 | $120 | $345.3K |
| B4154 | Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or… | 1 | 10 | 950 | $210 | $250.7K |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | 2 | 10 | 420 | $150 | $175.3K |
| T4525 | Adult sized disposable incontinence product, protective underwear/pull-on, small size, each | 1 | 10 | 120 | $120 | $168.7K |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | 2 | 10 | 370 | $190 | $161K |
| B4152 | Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include… | 1 | 10 | 1,080 | $150 | $151.9K |
Showing 1–10 of 86
Other providers in the same ZIP code as Sakrx, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.